Investigational Therapeutics for Patients with COVID-19


The range of medical therapeutics to treat corona virus condition 2019 (COVID-19) is growing and evolving fast, including both medicinals approved by U.S. Food and Drug Administration (FDA) and medicinals made available under FDA emergency use authorization (EUA). CDC dynamically encourages clinicians, cases and their counselors, and health system directors to regularly consult the COVID-19 Treatment Guidelines external icon published by the National Institutes of Health (NIH). The treatment and management recommendations in these guidelines are grounded on scientific proof and expert opinion and are much modernized. Current clinical management of COVID-19 consists of infection forestallment and control measures and supporting care, including supplemental oxygen and mechanical ventilatory support when indicated. FDA has approved one medicinal, remdesivir (Veklury), for the treatment of COVID-19 in certain situations.



 


    Related Conference of Investigational Therapeutics for Patients with COVID-19

    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Investigational Therapeutics for Patients with COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in